These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38857053)

  • 21. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C.
    Whitworth H; Sartain SE; Kumar R; Armstrong K; Ballester L; Betensky M; Cohen CT; Diaz R; Diorio C; Goldenberg NA; Jaffray J; Keegan J; Malone K; Randolph AG; Rifkin-Zenenberg S; Leung WS; Sochet A; Srivaths L; Zia A; Raffini L
    Blood; 2021 Jul; 138(2):190-198. PubMed ID: 33895804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review.
    Laçinel Gürlevik S; Günbey C; Ozsurekci Y; Oygar PD; Kesici S; Gocmen R; Aydin O; Temucin Ç; Tufan E; Terzi K; Baltu D; Ozturk TT; Teksam O; Ozen S; Oguz KK; Cengiz AB; Yalnızoglu D
    Eur J Paediatr Neurol; 2022 Mar; 37():139-154. PubMed ID: 35287009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019.
    Yin R; Feng W; Wang T; Chen G; Wu T; Chen D; Lv T; Xiang D
    J Med Virol; 2020 Oct; 92(10):1782-1784. PubMed ID: 32293714
    [No Abstract]   [Full Text] [Related]  

  • 25. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
    Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
    J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
    García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
    Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection.
    Xu Y; Zhuang Y; Kang L
    Med Sci Monit; 2021 Jun; 27():e932962. PubMed ID: 34145211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurological complications and infection mechanism of SARS-COV-2.
    Wan D; Du T; Hong W; Chen L; Que H; Lu S; Peng X
    Signal Transduct Target Ther; 2021 Nov; 6(1):406. PubMed ID: 34815399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis.
    Noval Rivas M; Porritt RA; Cheng MH; Bahar I; Arditi M
    Front Immunol; 2022; 13():941009. PubMed ID: 35874696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of SARS-CoV-2 and common cold coronavirus-specific T-cell responses in MIS-C and Kawasaki disease children.
    Hsieh LE; Grifoni A; Sidney J; Shimizu C; Shike H; Ramchandar N; Moreno E; Tremoulet AH; Burns JC; Franco A
    Eur J Immunol; 2022 Jan; 52(1):123-137. PubMed ID: 34599760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics, Outcomes, and Severity Risk Factors Associated With SARS-CoV-2 Infection Among Children in the US National COVID Cohort Collaborative.
    Martin B; DeWitt PE; Russell S; Anand A; Bradwell KR; Bremer C; Gabriel D; Girvin AT; Hajagos JG; McMurry JA; Neumann AJ; Pfaff ER; Walden A; Wooldridge JT; Yoo YJ; Saltz J; Gersing KR; Chute CG; Haendel MA; Moffitt R; Bennett TD
    JAMA Netw Open; 2022 Feb; 5(2):e2143151. PubMed ID: 35133437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain magnetic resonance imaging findings in children with neurological complications of coronavirus disease 2019 (Omicron variant): a multicenter retrospective observational study.
    Zhao C; Wang Y; Hou J; Xin M; Jiang Q; Han M; Li X; Shen Y; Wang X; Wang M; Jin Y
    Pediatr Radiol; 2024 May; 54(6):1012-1021. PubMed ID: 38538753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term neurological sequelae of SARS-CoV-2 infection.
    Nat Med; 2022 Nov; 28(11):2269-2270. PubMed ID: 36192556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurological manifestations in 404 COVID-19 patients in Washington State.
    Agarwal P; Ray S; Madan A; Tyson B
    J Neurol; 2021 Mar; 268(3):770-772. PubMed ID: 32761507
    [No Abstract]   [Full Text] [Related]  

  • 38. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19.
    Tsatsakis A; Calina D; Falzone L; Petrakis D; Mitrut R; Siokas V; Pennisi M; Lanza G; Libra M; Doukas SG; Doukas PG; Kavali L; Bukhari A; Gadiparthi C; Vageli DP; Kofteridis DP; Spandidos DA; Paoliello MMB; Aschner M; Docea AO
    Food Chem Toxicol; 2020 Dec; 146():111769. PubMed ID: 32979398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological infection with SARS-CoV-2 - the story so far.
    Solomon T
    Nat Rev Neurol; 2021 Feb; 17(2):65-66. PubMed ID: 33414554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.